| Morgan Stanley's Strategic Reduction in Celcuity Inc Holdings | 10/07 20:11 | gurufocus.com |
| Can Celcuity (CELC) Climb 87.59% to Reach the Level Wall Street Analysts Expect? | 09/10 10:56 | zacks.com |
| Celcuity (CELC) Upgraded to Buy: Here's Why | 08/20 13:00 | zacks.com |
| Celcuity Inc. (CELC) Q2 2024 Earnings Call Transcript | 08/16 15:50 | seekingalpha.com |
| Celcuity Inc. Reports Second Quarter Financial Results and Provides Corporate Update | 08/14 16:01 | globenewswire.com |
| Celcuity Inc. Schedules Release of Second Quarter 2024 Financial Results and Webcast/Conference Call | 08/07 07:05 | globenewswire.com |
| Celcuity: Flying A Phase 3 Trial Right Under Your Nose | 07/05 00:05 | seekingalpha.com |
| Celcuity To Participate in Jefferies Global Healthcare Conference | 06/03 16:01 | globenewswire.com |
| Celcuity Announces Pricing of Underwritten Common Stock Offering | 05/30 07:36 | globenewswire.com |
| Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing | 05/30 07:00 | globenewswire.com |